Farmers & Merchants Investments Inc’s Eledon Pharmaceuticals ELDN Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.9K	Buy	+6,321	New	+$23K	﹤0.01%	566

Other funds holding ELDN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PAM

Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $137M AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

PNFS

PW Nova Financial Services Newtown, Pennsylvania $466M AUM

Farmers & Merchants Investments Inc's ELDN Position: Q2 2026 in Review

Farmers & Merchants Investments Inc opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 6,321 shares worth $24.9K. The stake represents ﹤0.01% of the portfolio and ranks #566 among its holdings.

62 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Farmers & Merchants Investments Inc held 6,321 shares of Eledon Pharmaceuticals worth $24.9K as of Q2 2026.
Eledon Pharmaceuticals was a new Farmers & Merchants Investments Inc position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of Farmers & Merchants Investments Inc's portfolio in Q2 2026, its #566 holding.
62 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Farmers & Merchants Investments Inc's 13F filing for Q2 2026, filed 20 Jul 2026.